← Open Payments lookup

ELIZABETH COFFMAN: Open Payments

NPI 1083125017 · HENDERSON, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,048 in 54 payments from 9 companies in 2025. Trend: 2023 $17 · 2024 $559 · 2025 $1,048

Food & beverage: $1,048
CompanyPaymentsAmount
ABBVIE INC.13$286
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)14$178
Otsuka America Pharmaceutical, Inc.8$160
Vanda Pharmaceuticals Inc.6$139
Neurocrine BioSciences, Inc.6$120
Teva Pharmaceuticals USA, Inc.3$68
Takeda Pharmaceuticals U.S.A., Inc.2$53
E.R. Squibb & Sons, L.L.C.1$29
Supernus Pharmaceuticals, Inc.1$14

Products named: VRAYLAR, CAPLYTA, FANAPT, REXULTI, INGREZZA, TRINTELLIX, AUSTEDO XR, COBENFY.

Industry payments across NV — which companies pay providers there.